GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Uni-Bio Science Group Ltd (HKSE:00690) » Definitions » Cash And Cash Equivalents

Uni-Bio Science Group (HKSE:00690) Cash And Cash Equivalents : HK$65.0 Mil (As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Uni-Bio Science Group Cash And Cash Equivalents?

Uni-Bio Science Group's quarterly cash and cash equivalents increased from Dec. 2023 (HK$129.24 Mil) to Jun. 2024 (HK$153.96 Mil) but then stayed the same from Jun. 2024 (HK$153.96 Mil) to Dec. 2024 (HK$65.01 Mil).

Uni-Bio Science Group's annual cash and cash equivalents increased from Dec. 2022 (HK$98.22 Mil) to Dec. 2023 (HK$129.24 Mil) but then declined from Dec. 2023 (HK$129.24 Mil) to Dec. 2024 (HK$65.01 Mil).


Uni-Bio Science Group Cash And Cash Equivalents Historical Data

The historical data trend for Uni-Bio Science Group's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Uni-Bio Science Group Cash And Cash Equivalents Chart

Uni-Bio Science Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.01 83.61 98.22 129.24 65.01

Uni-Bio Science Group Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 98.22 95.83 129.24 153.96 65.01

Uni-Bio Science Group Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Uni-Bio Science Group  (HKSE:00690) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Uni-Bio Science Group Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Uni-Bio Science Group's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Uni-Bio Science Group Business Description

Traded in Other Exchanges
N/A
Address
No. 20 Science Park East Avenue, Unit 502, 5th Floor, Hong Kong Science Park, Shatin, New Territories, Hong Kong, HKG
Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC.
Executives
Automatic Result Limited
Mjkpc Holdings Limited 2201 Interest of corporation controlled by you
Leung Kingsley
Yau Kwok Wing Tony 2201 Interest of corporation controlled by you
Century Ally Ventures Limited 2201 Interest of corporation controlled by you
Fih (bvi) Limited 2201 Interest of corporation controlled by you
Futec Investments Limited 2201 Interest of corporation controlled by you
Tmf (cayman) Ltd 2201 Interest of corporation controlled by you
Mjkpc Holdings Limited
Petite Arbre Limited 2201 Interest of corporation controlled by you
Tmf (cayman) Ltd. 2301 Trustee
Xjg Capital Management Limited 2201 Interest of corporation controlled by you
Lau Kan Sum 2307 Founder of a discretionary trust who can infl
Credit Suisse Trust Limited 2301 Trustee

Uni-Bio Science Group Headlines

No Headlines